image
image
user-login
Patent search/

BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USES THEREOF

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USES THEREOF

PCT NATIONAL PHASE APPLICATION

Published

date

Filed on 23 December 2022

Patent Information

Application ID202217074806
Date of Application23/12/2022

Documents

NameDate
202217074806-FORM 3 [19-06-2023(online)].pdf19/06/2023
202217074806-Correspondence-230323.pdf29/03/2023
202217074806-Others-230323.pdf29/03/2023
202217074806-Proof of Right [13-03-2023(online)].pdf13/03/2023
202217074806-Correspondence-230123.pdf27/01/2023
202217074806-GPA-230123.pdf27/01/2023
202217074806-FORM-26 [06-01-2023(online)].pdf06/01/2023
202217074806.pdf26/12/2022
202217074806-COMPLETE SPECIFICATION [23-12-2022(online)].pdf23/12/2022
202217074806-DECLARATION OF INVENTORSHIP (FORM 5) [23-12-2022(online)].pdf23/12/2022
202217074806-DRAWINGS [23-12-2022(online)].pdf23/12/2022
202217074806-FORM 1 [23-12-2022(online)].pdf23/12/2022
202217074806-POWER OF AUTHORITY [23-12-2022(online)].pdf23/12/2022
earn

Refer a friend